2Kahlos K,Soini Y,Sily M,et al.Up-regulation of thioredoxinand thioredoxin reductase in human malignant pleural mesotheli-oma[J].Int J Cancer,2001,95(3):198-204.
3Yamada M,Tomida A,Yoshikawa H,et al.Increased expres-sion of thioredoxin/adult T-cell leukemia-derived factor in cispla-tin-resistant human cancer cell lines[J].Clin Cancer Res,1996,2(2):427-432.
4Shao L,Diccianni MB,Tanaka T,et al.Thioredoxin expressionin primary T-cell acute lymphoblastic leukemia and its therapeu-tic implication[J].Cancer Res,2001,61(19):7333-7338.
5Chen XP,Liu S,Tang WX,et al.Nuclear thioredoxin-1is re-quired to suppress cisplatin-mediated apoptosis of MCF-7cells[J].Biochem Biophys Res Commun,2007,361(2):362-366.
6Noguchi S.Predictive factors for response to docetaxel in humanbreast cancers[J].Cancer Sci,2006,97(9):813-820.
7Yamada M,Tomida A,Yoshikawa H,et al.Overexpression ofthioredoxin does not confer resistance to cisplatin in transfectedhuman ovarian and colon cancer cell lines[J].Cancer ChemotherPharmacol,1997,40(1):31-37.
8Sun L,Gorospe JR,Hoffman EP,et al.Decreased platelet ex-pression of myosin regulatory light chain polypeptide(MYL9)and other genes with platelet dysfunction and CBFA2/RUNX1mutation:insights from platelet expression profiling[J].JThromb Haemost,2007,5(1):146-154.
9Hirasawa Y,Arai M,Imazeki F,et al.Methylation status ofgenes upregulated by demethylating agent 5-aza-2′-deoxycytidinein hepatocellular carcinoma[J].Oncology,2006,71(1-2):77-85.
10Wagner GF,Dimattia GE.The stanniocalcin family of proteins[J].J Exp Zoolog A Comp Exp Biol,2006,305(9):769-780.
